Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Tata Chemicals...

    Tata Chemicals launches Medikarb, India’s first branded pharmaceutical grade sodium bicarbonate

    Written by Ruby Khatun Khatun Published On 2018-03-24T10:15:04+05:30  |  Updated On 24 March 2018 10:15 AM IST
    Tata Chemicals launches Medikarb, India’s first branded pharmaceutical grade sodium bicarbonate

    Mumbai: Tata Chemicals Ltd., the country’s leading producer of Soda Ash and Sodium Bicarbonate, announced the launch of MedikarbTM – India’s first branded pharmaceutical grade sodium bicarbonate for pharma API and formulation manufacturing.


    MedikarbTM will be manufactured in state of the art FDA certified facilities that are compliant with GMP standards to ensure the highest quality product conforming to Indian Pharmacopoeia specifications.


    Sanjiv Lal, COO, India Chemicals Operations, Tata Chemicals Ltd. said, “MedikarbTM is India’s first branded premium grade of sodium bicarbonate suitable for use as an Active Pharmaceutical Ingredient (API) and as an excipient in pharma formulations. This will give Indian pharma manufacturers a high-quality product manufactured in a state of the art FDA certified facility from a trusted brand. MedikarbTM will be available through our dedicated distributor network.


    This is another step in the direction of providing added value through customized products to meet different customer requirements in Health Care, Personal Care, Food, Feed and Industrial applications.”


    MedikarbTM will be produced through a highly mechanized automated manufacturing process designed as per GMP principles. Quality of the end product is assured through an end-to-end Tata Quality Management System (QMS), with the product manufactured, processed, packed and distributed under the applicable licensing and operational guidelines.


    Customers will also have the backing of technical sales support through an in-house R&D and Technical Services team. Customers can order small lots as per their requirement and systems are aligned to cater to express deliveries.


    High-purity sodium bicarbonate is used as an alkali in the pharmaceutical industry. Sodium bicarbonate is a vital ingredient in the production of effervescent antacids, analgesic tablets and powders, vitamin supplements, injectable powders, toothpaste and antacid gel formulations. It is also used as a buffering agent, providing bicarbonate ions to balance the pH during blood purification.


    Tata Chemicals' with its sodium bicarbonate business has a presence in both domestic and global market. With an annual capacity of 100,000 MT in India, the company also has two other brands SodakarbTM, customized for use as a food additive and AlkakarbTM, for use in animal feed. This introduction of Medikarb TM as a customized product will cater specifically to the pharmaceutical industry.

    APIbrandedFDAGMP standardsgradeIndian Pharmacopoeia specificationslaunchesMedikarbpharmaceuticalQuality Management SystemSanjiv LalSodium bicarbonateTata Chemicals
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok